USPTO serial 79295832
14 SI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 26, 2022
- Examiner
- HOWELL, MATTHEW P
- Law office
- TMO LAW OFFICE 123
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with 14 SI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 041 | Educational and instruction services, namely, organizing events for educational and teaching purposes relating to arts, crafts, sports and general knowledge; teaching in the field of drug discovery and development; educating at universities and graduate schools; arranging, conducting and organization of seminars; arranging, conducting and organization of symposiums, lecture meetings, workshops and study groups; arranging, conducting and organization of educational seminars, symposiums, lecture meetings, workshops and study groups in the field of drug discovery and development; providing online non-downloadable electronic publications in the nature of magazines, newsletters, journals and books in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; reference libraries of literature and documentary records; book rental; providing online music, sound recordings, videos featuring information and instruction on nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering, images and character text information, non-downloadable; educational services in the nature of providing exhibits of academic materials in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicine, chemicals and engineering; art exhibitions; publication of books; movie theatre presentations, namely, movie showing and movie film production and distribution; production of videotape film in the field of education, culture, entertainment or sports, not for movies or television programs and not for advertising or publicity | ACTIVE | — |
| 042 | Designing of machines, apparatus, instruments, including their parts, or systems composed of such machines, apparatus and instruments; pharmaceutical, medicine and chemical industrial design services for use in medicines and engineering design services, not for advertising; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for use in genome research or the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; data conversion of electronic information using computers technological advice relating to computers, automobiles and other industrial machines requiring highly specialized knowledge, skills and experiences for proper operation, namely, computer technology consultancy, automobile transmission diagnostic consulting and industrial machine part design consulting; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering; quality control assessment services for others; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; testing, inspection or research of chemicals or reagents; providing information and consultancy on testing, inspection or research of pharmaceuticals, chemicals, reagents, cosmetics or foodstuffs; scientific or laboratory testing, inspection or research of nucleic acids, chemicals and pharmaceuticals for drug development and medical research purposes, and providing scientific information and research consultancy relating thereto; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; genomic experiments, analyses, research, assays, tests, inspection, detection or verification, namely, scientific genomic analyses, scientific genomic research, custom design and development of biochemical genomic assays, genome amplification and functional and structural analysis of genomes; scientific research consultancy, advice and providing information in the field of genomic experiments, analyses, research, assays, tests, inspection, detection or verification; scientific and technological services, namely, testing, analysis surveying, research or data analysis in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials and bioengineering; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceuticals for others; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research on machines, apparatus and instruments, namely, testing the functionality of machines, research on machines and technology research in the field of medical instruments and drug manufacturing machines; rental of measuring apparatus; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; cloud computing, namely, providing temporary use of on-line non-downloadable cloud computing software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; software as a service (SaaS) services featuring software for enabling, supporting and accelerating processes of RNA-targeted drug discovery and development for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; electronic storage services for archiving electronic data; cloud server storage services on the internet for electronic files; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing online non-downloadable computer software for analyzing, testing, screening, designing, development and research of nucleic acids, pharmaceuticals and chemicals; providing online non-downloadable computer software for drug discovery screening; providing online non-downloadable computer software for genome research and development research of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments and foodstuffs; rental of laboratory apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Veritas In Silico Inc.
- Other trademarks owned by Veritas In Silico Inc.
- Other trademarks owned by Veritas In Silico Inc.
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named 14 SI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 20, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 20, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 20, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 11, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 11, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 11, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 11, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 31, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 31, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 26, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 26, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 4, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 16, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 16, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 14, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 19, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 19, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 19, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 5, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 4, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 3, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 30, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 11, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 11, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 11, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 10, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 7, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 17, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 17, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 27, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 19, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 15, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |